在胃肠道瘤中基因的临床活性
Nadia Saoudi Gonzalez1,2, Giorgio Patelli1,3,4, Giovanni Crisafulli1
1IFOM-ETS, The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
Genes
|October 29, 2025
概括
精密瘤学通过基因组分析来推进癌症治疗. 在胃肠道癌症中识别可操作的基因组改变指导向治疗和临床试验选择,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 个性化医疗是个性化的医疗.
背景情况:
- 精确瘤学依赖于来自癌症基因组学和药物开发的分子标.
- 瘤基因组分析是癌症患者日常护理的组成部分,指导治疗决策.
- 挑战包括将基因组数据转化为可行的临床策略.
研究的目的:
- 为提供胃肠道 (GI) 癌症中可操作的基因组改变的最新概述.
- 讨论这些改变对临床决策的影响.
- 突出生物标志物在量身定制患者护理中的作用.
主要方法:
- 对肠道癌症的基因组分析现有文献的综述.
- 对已确定的预测生物标志物的分析 (例如,RAS突变,MSI状态,BRAF V600E,ERBB2放大,NTRK/RET/NRG1融合).
- 讨论临床试验预选计划及其影响.
主要成果:
- 在各种胃肠道癌症中确定了关键可操作的基因组变异.
- 强调了负预测生物标志物的重要性 (例如,针对抗EGFR治疗的RAS突变).
- 强调了积极预测生物标志物在指导治疗选择中的作用.
结论:
- 可操作的基因组改变对于 GI 癌症的个性化治疗策略至关重要.
- 生物标志物引导的选择改善了患者的治疗结果,并最大限度地降低了毒性.
- 导航基因组数据需要考虑药物可访问性和临床试验可用性.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.1K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
